Nexien BioPharma, Inc.
NXEN · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$239 | -$362 | -$626 | -$1,860 |
| Dep. & Amort. | $0 | $50 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $203 | $379 | $349 |
| Change in WC | $38 | $3 | $14 | $7 |
| Other Non-Cash | $137 | $25 | $158 | $1,413 |
| Operating Cash Flow | -$64 | -$82 | -$75 | -$91 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $20 | $0 | $147 | $78 |
| Stock Issued | $0 | $0 | $2 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $13 | $0 | $25 | $20 |
| Financing Cash Flow | $33 | $0 | $174 | $98 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$31 | -$82 | $99 | $7 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $35 | $117 | $18 | $11 |
| End Cash | $4 | $35 | $117 | $18 |
| Free Cash Flow | -$64 | -$82 | -$75 | -$91 |